![John Couch](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Network origin in John Couch first degree
Entity | Entity type | Industry | |
---|---|---|---|
DoubleTwist, Inc.
![]() DoubleTwist, Inc. Miscellaneous Commercial ServicesCommercial Services Doubletwist, Inc. provides genomic information and bioinformatics analysis technologies. The company is headquartered in Oakland, CA.
3
| Private Company | Miscellaneous Commercial Services | 3 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to John Couch via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
ACCELRYS, INC. | Packaged Software | Corporate Officer/Principal | |
SANGAMO THERAPEUTICS, INC. | Biotechnology | Director of Finance/CFO | |
Viewpoint (US) | Director/Board Member | ||
Oncomyx Therapeutics, Inc.
![]() Oncomyx Therapeutics, Inc. Packaged SoftwareTechnology Services Oncomyx Therapeutics, Inc. develops and operates software platform to orchestrate an immune response and treat cancer. Its platform's features include non-human pathogen, immuno-stimulatory, ability to multi-arm, and systemic delivery. The company was founded by Steve Potts, Michael Wood, Grant McFadden and is headquartered in Phoenix, AZ. | Packaged Software | Director of Finance/CFO | |
ATXCo, Inc.
![]() ATXCo, Inc. Pharmaceuticals: OtherHealth Technology ATXCo, Inc. develops clinical programs for the inhibition of fibrotic diseases. Its core asset is PAT-409, a Phase I ready autotaxin inhibitor for idiopathic pulmonary fibrosis (IPF), NASH (nonalcoholic steatohepatitis), PBC (primary biliary cholangitis), scleroderma and chronic kidney disease. The company is headquartered in San Diego, CA. | Pharmaceuticals: Other | Chief Executive Officer | |
University of Miami
![]() University of Miami Other Consumer ServicesConsumer Services University of Miami (Florida) is a private research university with students from around the world that is focused on teaching and learning, the discovery of new knowledge, and service to the South Florida region and beyond. The university was founded in 1925 and it is headquartered in Coral Gables, FL. | College/University | Corporate Officer/Principal | |
Federal Reserve System | General Government | Corporate Officer/Principal | |
University of California, Berkeley | College/University | Undergraduate Degree | |
MAP Pharmaceuticals LLC
![]() MAP Pharmaceuticals LLC Medical SpecialtiesHealth Technology MAP Pharmaceuticals, Inc. develops therapies and inhalation delivery technologies. The company was founded by Thomas A. Armer on July 3, 2003 and is headquartered in Irvine, CA. | Medical Specialties | Director/Board Member | |
PORTOLA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Russell Reynolds Associates, Inc.
![]() Russell Reynolds Associates, Inc. Miscellaneous Commercial ServicesCommercial Services Russell Reynolds Associates, Inc. provides executive recruitment services. Its services include chief executive officer and board advisory services, culture assessment, executive search, global supply chain and leadership assessment. The company was founded in 1969 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Director/Board Member | |
CALITHERA BIOSCIENCES, INC. | Biotechnology | Director/Board Member | |
Harvard Business School | College/University | Masters Business Admin | |
Russell Reynolds Associates, Inc. (Germany)
![]() Russell Reynolds Associates, Inc. (Germany) Miscellaneous Commercial ServicesCommercial Services Russell Reynolds Associates, Inc. engages in the provision of leadership advisory services. Its services include executive search, executive assessment, CEO succession, board evaluation, and transformation. The company was founded in 1985 and is headquartered in Frankfurt, Germany. | Miscellaneous Commercial Services | Director/Board Member | |
PERSPECTIVE THERAPEUTICS, INC. | Medical Specialties | Director/Board Member | |
Triumvira Immunologics USA, Inc.
![]() Triumvira Immunologics USA, Inc. Miscellaneous Commercial ServicesCommercial Services Triumvira Immunologics USA, Inc. develops and manufactures novel T cell therapies for cancer. The company is based in Austin, TX and has subsidiaries in Canada. Paul Lammers has been the CEO of the company since 2018. | Miscellaneous Commercial Services | President | |
Pharmacopeia LLC
![]() Pharmacopeia LLC Pharmaceuticals: MajorHealth Technology Pharmacopeia LLC develops small molecule therapeutics to address significant medical needs. The firm operates as clinical development stage Biopharmaceutical Company which focuses on discovering and developing novel small molecule therapeutics to address medical needs. The company was founded by John J. Baldwin in February 2002 and is headquartered in Cranbury, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal | |
The Boston Consulting Group, Inc.
![]() The Boston Consulting Group, Inc. Miscellaneous Commercial ServicesCommercial Services The Boston Consulting Group, Inc. engages in the provision of management consulting services. It specializes in automotive and mobility; biopharmaceuticals; consumer products; education; oil and gas; power and utilities; engineered products and infrastructure; financial institutions; and health care payers, providers, and services. It offers big data and advanced analytics; change management; client learning and enablement; and corporate development and financial services. The company was founded by Bruce Doolin Henderson in 1963 and is headquartered in Boston, MA. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
University College London | College/University | Doctorate Degree | |
FARITEC HOLDINGS LTD | Information Technology Services | President | |
XILIO THERAPEUTICS, INC. | Pharmaceuticals: Major | Chief Executive Officer | |
Pomona College
![]() Pomona College Other Consumer ServicesConsumer Services Pomona College offers curriculum in the arts, humanities, social sciences and natural sciences. It was founded in 1887 and it is headquartered in Claremont, CA | College/University | Undergraduate Degree | |
Pharmasset, Inc.
![]() Pharmasset, Inc. Pharmaceuticals: OtherHealth Technology Pharmasset, Inc. developed drugs to treat viral infections. It focued in the development of oral therapeutics for the treatment of hepatitis C virus (HCV) infection. The company was founded in 1998 and was headquartered in Princeton, NJ. | Pharmaceuticals: Other | Director/Board Member | |
LaSalle Venture Advisers | Founder | ||
EOS Biotechnology, Inc.
![]() EOS Biotechnology, Inc. Pharmaceuticals: MajorHealth Technology EOS Biotechnology, Inc. develops therapeutic and diagnostic drugs. The company was founded by Herbert L. Heyneker, John Lowe, David H. Mack, David W. Martin, Richard Murray, and Stephen W. Weiss and is headquartered in Fermont, California. | Pharmaceuticals: Major | President | |
TBG DIAGNOSTICS LIMITED | Pharmaceuticals: Major | Director/Board Member | |
HAYA Therapeutics SA
![]() HAYA Therapeutics SA BiotechnologyHealth Technology HAYA Therapeutics SA is a Swiss precision medicines company that focuses on developing programmable therapeutics targeting regulatory RNAs derived from the dark genome to reprogram pathological cell states for a broad range of diseases, including cardiovascular disease and cancer. The company's discovery engine identifies novel targets and drug candidates with the potential for greater efficacy and safety than existing treatments. HAYA's lead therapeutic candidate is HTX-001, an antisense oligonucleotide targeting WISPER that is a heart-specific lncRNA known to be a fundamental regulator of pathological cardiac fibrosis in the context of heart failure. The company is headquartered at the Life Sciences Park Biopôle in Lausanne, CH, with laboratory facilities at JLABS @ San Diego. The company was founded by Samir Ounzain and Daniel Blessing, and Samir Ounzain has been the CEO since incorporation. | Biotechnology | Chairman | |
Stanford University | College/University | Masters Business Admin | |
PharmAkea, Inc.
![]() PharmAkea, Inc. Pharmaceuticals: MajorHealth Technology PharmAkea, Inc. develops small molecule drug candidates against protein targets involved in fibro proliferative diseases. It discovers and develops small molecule therapeutics directed at cancer and fibrotic diseases. The company was founded by John Howard Hutchinson, Kevin Holme, and Jilly Evans in 2012 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Chief Executive Officer | |
Clarke Industrial Engineering, Inc.
![]() Clarke Industrial Engineering, Inc. Industrial MachineryProducer Manufacturing Clarke Industrial Engineering, Inc. manufactures shutter valves. It specializes in gas lift, gas compression, separators, refinery valves, and tank valves. The company was founded by Kyle Daniels in 2011 and is headquartered in North Kingstown, RI. | Industrial Machinery | Director/Board Member | |
Sidecar Therapeutics, Inc.
![]() Sidecar Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Sidecar Therapeutics, Inc. operates as a biotechnology and pharmaceutical company. It focuses on drug development for fibrotic disease. The company was founded in 2016 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Chief Executive Officer | |
Aegle Therapeutics Corp.
![]() Aegle Therapeutics Corp. BiotechnologyHealth Technology Aegle Therapeutics Corp. is a biotechnology company, which isolates extracellular vesicles including exosomes (“EVs”) secreted by allogeneic bone marrow derived mesenchymal stem cells to treat dystrophic epidermolysis bullosa (“DEB”), a rare pediatric connective tissue disorder. Its EV therapy has the potential to demonstrate a safer, lower cost means of harnessing the regenerative healing power of stem cells without using the cells. The company was founded by Evangelos V. Badiavas, and Robert F. Williamson III in 2013 and is headquartered in Miami, FL. | Biotechnology | Founder | |
BioTheryX, Inc.
![]() BioTheryX, Inc. Pharmaceuticals: MajorHealth Technology BioTheryX, Inc. pengages in the development of clinical drugs. It focuses on the restoration of protein homeostasis, including protein degradation and modulation, and multi-kinase inhibition. The company was founded by David I. Stirling and Lawrence Zaslow in 2007 and is headquartered in Chappaqua, NY. | Pharmaceuticals: Major | Chief Executive Officer |
Statistics
International
United States | 40 |
Germany | 2 |
United Kingdom | 2 |
South Africa | 2 |
Australia | 2 |
Sectoral
Health Technology | 24 |
Consumer Services | 7 |
Commercial Services | 6 |
Technology Services | 5 |
Government | 2 |
Operational
Director/Board Member | 20 |
Corporate Officer/Principal | 8 |
Director of Finance/CFO | 8 |
Chief Executive Officer | 7 |
President | 6 |
Most connected contacts
Insiders | |
---|---|
Robert Williamson | 25 |
Henry Ward Wolff | 15 |
Simon M. Tomlinson | 7 |
- Stock Market
- Insiders
- John Couch
- Company connections